CCL2 and amyotrophic lateral sclerosis: Through GABAA receptors, neurosteroids can inhibit nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation, the production of inflammatory mediators, and monocyte chemoattractant protein-1 (MCP-1) secretion, all mechanisms that have been described in ALS [11,12].